FDA officials announced that the agency will again delay its decision on the over-the-counter status of Plan B, or the "morning-after pill." The agency claims that it needs more time to evaluate how it will enforce an over-the-counter regulation. The agency also decided to arbitrarily raise the age limit for receiving Plan B without a prescription from 16 to 17. The agency was initially required to decide the Plan B OTC status in January, but the agency has delayed a decision ever since. In fact, Senators Hillary Rodham Clinton and Pat Murray approved the confirmation of FDA Administrator Lester Crawford contingent upon an agency decision on Plan B. More on Plan B: FDA Ignores Experts, Rejects Plan B for Over-the-Counter Use (5/17/2004) and Details Emerge on Data Rejected in Morning-after Pill Decision (6/28/2004).